Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Thomas

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Computers in Biology and Medicine|April 24, 2018
Accurate segmenting of cervical tumors in PET imaging based on similarity between adjacent slicesLiyuan Chen, Chenyang Shen, Zhiguo Zhou, et al.
Physics in Medicine and Biology|October 3, 2018
Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics modelXi Chen, Zhiguo Zhou, Raquibul Hannan, et al.
MMWR. Morbidity and Mortality Weekly Report|August 11, 2017
Summary of Notifiable Noninfectious Conditions and Disease Outbreaks: Surveillance Data Published Between April 1, 2016 and January 31, 2017 - United StatesKimberly Thomas, Ruth Jajosky, Ralph J Coates, et al.
Head & Neck|March 7, 2017
Improving patient health engagement with mobile texting: A pilot study in the head and neck postoperative settingAlan Sosa, Nathan Heineman, Kimberly Thomas, et al.
Journal of Medical Economics|January 17, 2022
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspectiveAdrian Kilcoyne, Edward Jordan, Allen Zhou, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 21, 2022
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service EnglandAdrian Kilcoyne, Edward Jordan, Kimberly Thomas, et al.
Pharmacoeconomics - Open|September 15, 2022
Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in CanadaMoogeh Baharnoori, Virender Bhan, Fraser Clift, et al.
Practical Radiation Oncology|July 2, 2017
Deep inspiration breathhold for left-sided breast cancer patients with unfavorable cardiac anatomy requiring internal mammary nodal irradiationOsama Mohamad, Jean Shiao, Bo Zhao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 29, 2006
Terbinafine-induced hepatic failure requiring liver transplantationZeeshan Perveze, Mark W Johnson, Raymond A Rubin, et al.
Journal of Comparative Effectiveness Research|August 22, 2023
Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in CanadaVirender Bhan, Fraser Clift, Moogeh Baharnoori, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Computers in Biology and Medicine|April 24, 2018
Accurate segmenting of cervical tumors in PET imaging based on similarity between adjacent slicesLiyuan Chen, Chenyang Shen, Zhiguo Zhou, et al.
Physics in Medicine and Biology|October 3, 2018
Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics modelXi Chen, Zhiguo Zhou, Raquibul Hannan, et al.
MMWR. Morbidity and Mortality Weekly Report|August 11, 2017
Summary of Notifiable Noninfectious Conditions and Disease Outbreaks: Surveillance Data Published Between April 1, 2016 and January 31, 2017 - United StatesKimberly Thomas, Ruth Jajosky, Ralph J Coates, et al.
Head & Neck|March 7, 2017
Improving patient health engagement with mobile texting: A pilot study in the head and neck postoperative settingAlan Sosa, Nathan Heineman, Kimberly Thomas, et al.
Journal of Medical Economics|January 17, 2022
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspectiveAdrian Kilcoyne, Edward Jordan, Allen Zhou, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 21, 2022
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service EnglandAdrian Kilcoyne, Edward Jordan, Kimberly Thomas, et al.
Pharmacoeconomics - Open|September 15, 2022
Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in CanadaMoogeh Baharnoori, Virender Bhan, Fraser Clift, et al.
Practical Radiation Oncology|July 2, 2017
Deep inspiration breathhold for left-sided breast cancer patients with unfavorable cardiac anatomy requiring internal mammary nodal irradiationOsama Mohamad, Jean Shiao, Bo Zhao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 29, 2006
Terbinafine-induced hepatic failure requiring liver transplantationZeeshan Perveze, Mark W Johnson, Raymond A Rubin, et al.
Journal of Comparative Effectiveness Research|August 22, 2023
Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in CanadaVirender Bhan, Fraser Clift, Moogeh Baharnoori, et al.
Pageof 3